OR WAIT null SECS
March 15, 2016
The authors present analysis of the state of control of intermediate identity and quality, based on analysis of recently submitted DMFs.
March 02, 2016
Asking the right questions is crucial to establishing a biopharmaceutical facility design.
Gauging the adequate level and type of screening is the challenge when identifying relevant crystalline forms.
Hazardous reagents can prove to be faster, simpler, cheaper, and greener.
February 24, 2016
ICIG’s CordenPharma Group expands fermentation-based production technology with acquisition of Sandoz Site.
February 02, 2016
Scale-down modeling is instrumental in supporting the development of downstream biopharma manufacturing processes.
Hazardous reagents can simplify processes and provide higher yields and purities.
The chemical distribution industry has formed an international chemical trade association to address global issues.
February 01, 2016
Sustainable harvesting combined with CMO expertise helped Centroflora CMS ensure supply continuity after it acquired Boehringer Ingelheim's non-captive API phytochemicals portfolio.
Time and sensitivity are essential for analytical technologies in all phases of biopharma development.
